Gilead And EVOQ Ink Deal Worth up to $685M For Autoimmune Diseases
Gilead Sciences and EVOQ have announced a potential $685M collaboration around autoimmune disease.
Source: insideprecisionmedicine.com
Stay updated with breaking news from William Brinkerhoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gilead Sciences and EVOQ have announced a potential $685M collaboration around autoimmune disease.
Evoq Therapeutics Inc., a pharmaceutical company spun off from the University of Michigan in 2016, could be set for a big payday.
Behind the digital tools that make the industrial internet of things (IIOT) in the power generation and chemical process industries are people. The 2021
(Page 1) Ontario Power Generation 3D Scanning Team. When Ontario Power Generation (OPG)—a Crown corporation responsible for about half of the electricity